CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 29, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…
View More Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Analysis of social media messages between care home staff on the coronavirus front line reveal…
View More Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
Concerns have been raised that the use of a common group of medications called RAS…
View More RAS inhibitors not linked to increased risk of death from COVID-19
Swedish confidence in the nation’s strategy to fight the coronavirus pandemic has slumped, with concerns…
View More Covid-19 pandemic: Swedes lose faith in ‘herd immunity’ strategy with coronavirus rampant
COVID-19 prevalence surveys that detect levels of antibodies to determine whether people were infected in…
View More COVID-19 antibody surveys underestimate infections: study
While staying close to nature can lead to many health benefits, a recent study has…
View More A regular dose of nature may improve mental health during Covid-19 pandemic
Less than a month ago, the Food and Drug Administration said hospitals could use remdesivir,…
View More Coronavirus: Remdesivir’s failure is a warning for Covid-19 vaccines
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19…
View More Pfizer seeking emergency use of its COVID-19 vaccine in US
Afro-Caribbean people with end stage kidney disease (ESKD) are more likely to be hospitalized with…
View More Afro-Caribbean patients with severe kidney disease at greater risk of hospitalisation from COVID-19
One of the first spectroscopic imaging-based studies of neurological injury in COVID-19 patients has been…
View More Early details of brain damage in COVID-19 patients